Search
for

    Sort by

    Research 30 of 1000+

    1. Mesotherapy for Treatment of Male-Type Alopecia 2007
    2. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial Archives of Dermatological Research · 2024
    3. A Randomized Controlled, Single-Observer Blinded Study on the Safety and Efficacy of a Combination of 678nm Helmet-Type Low-level Laser Therapy and Topical Minoxidil 5% Versus Topical Minoxidil 5% Alone in the Treatment of Male Androgenetic Alopecia Journal of dermatology research reviews & reports · 2024
    4. The type of androgenetic alopecia and quality of life (QoL) in male patients Journal of the Medical Sciences · 2022
    5. Assessing the Efficacy and Quality of Life Improvements of Botulinum Toxin Type A With Topical Minoxidil versus Topical Minoxidil in Male Androgenetic Alopecia: A Randomized Controlled Trial Research Square (Research Square) · 2024
    6. Male androgenetic alopecia Human health handbooks · 2012 · 1 citations
    7. Androgenetische Alopezie beim Mann . Male androgenetic alopecia Zeitschrift für Hautkrankheiten · 2002 · 1 citations
    8. Bilateral temporal alopecia in male androgenetic alopecia: An unusual new presentation Indian Journal of Dermatology Venereology and Leprology · 2024
    9. Topical minoxidil therapy for hereditary male pattern alopecia. PubMed · 1987 · 14 citations
    10. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss Journal of The American Academy of Dermatology · 1999 · 46 citations
    11. Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia Expert Opinion on Investigational Drugs · 1999 · 32 citations
    12. Male pattern androgenetic alopecia in an Indian context: a perspective study Journal of The European Academy of Dermatology and Venereology · 2007 · 28 citations
    13. In silico screening of effective inhibitor of 5α-reductase type 1 for androgenic alopecia treatment Natural Product Research · 2021 · 1 citations
    14. Identification of Immune Microenvironment Changes, Immune-Related Pathways and Genes in Male Androgenetic Alopecia Research Square (Research Square) · 2023
    15. FINASTERIDE AS A TREATMENT FOR MALE ANDROGENETIC ALOPECIA e-Jurnal Medika Udayana · 2013
    16. ST008 Male androgenetic alopecia: A new treatment paradigm Journal of The European Academy of Dermatology and Venereology · 1997
    17. Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite British Journal of Dermatology · 2011
    18. Identification of immune microenvironment changes, immune-related pathways and genes in male androgenetic alopecia Medicine · 2023
    19. “Cold” X5 Hairlaser™ used to treat male androgenic alopecia and hair growth: an uncontrolled pilot study BMC Research Notes · 2014 · 15 citations
    20. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies. PubMed · 2001 · 10 citations
    21. Classification scale for male and female androgenetic alopecia. Clinical Pharmacology & Therapeutics · 1996 · 6 citations
    22. Dermatology Life Quality Index in Thai Male Androgenetic Alopecia Patients attending Dermatology Outpatient Clinic JOURNAL OF THE MEDICAL ASSOCTATION OF THAILAND · 2021
    23. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? PubMed · 2005 · 12 citations
    24. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?]. PubMed · 1996 · 3 citations
    25. 42577 Application of the new clinical guidelines in frontal fibrosing alopecia of the male Journal of the American Academy of Dermatology · 2023
    26. Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2014
    27. Acquired Acrodermatitis Enteropathica in a 28-Year-Old Male with Type 1 Diabetes Case reports in dermatological medicine · 2021 · 2 citations
    28. trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes Biological and Pharmaceutical Bulletin · 2008 · 10 citations
    29. Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia) Dermatologic Surgery · 2001 · 89 citations
    30. Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia) Dermatologic Surgery · 2001 · 6 citations